Betaserc

Medicinal product

(Invented) name

Betaserc

Active substance (s)

Betahistino dihidrochloridas

Strength

16 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N07CA01, Betahistine

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2025-05-05

Date of renewal

Documents

2542_Betaserc 16mg tabl_PL.docx

2542_Betaserc 16mg tabl_PZ.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Betahistino dihidrochloridas	16 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
117463	103568	1103568	lizdinė plokštelė	N63		Receptinis	LT/L/25/2542/001	Netiekiama	-	2025-08-01	No	-	-	Download
117464	103569	1103569	lizdinė plokštelė	N84		Receptinis	LT/L/25/2542/002	Netiekiama	-	2025-08-01	No	-	-	Download

Stadijos

Data	Stadija
2025-05-05	Registruotas